nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2E1—liver cancer	0.441	1	CbGaD
Desipramine—HTR2C—Sorafenib—liver cancer	0.0833	0.247	CbGbCtD
Desipramine—CYP2B6—Sorafenib—liver cancer	0.0517	0.153	CbGbCtD
Desipramine—CYP2C19—Sorafenib—liver cancer	0.0329	0.0972	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—liver cancer	0.0314	0.0929	CbGbCtD
Desipramine—CYP1A2—Sorafenib—liver cancer	0.0303	0.0897	CbGbCtD
Desipramine—ABCB1—Sorafenib—liver cancer	0.0265	0.0785	CbGbCtD
Desipramine—CYP2D6—Sorafenib—liver cancer	0.025	0.0739	CbGbCtD
Desipramine—ABCB1—Doxorubicin—liver cancer	0.0161	0.0476	CbGbCtD
Desipramine—CYP3A4—Sorafenib—liver cancer	0.0159	0.047	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—liver cancer	0.0152	0.0449	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—liver cancer	0.00964	0.0285	CbGbCtD
Desipramine—Gynaecomastia—Sorafenib—liver cancer	0.00115	0.0262	CcSEcCtD
Desipramine—Benazepril—MTHFR—liver cancer	0.000974	0.307	CrCbGaD
Desipramine—Erectile dysfunction—Sorafenib—liver cancer	0.000744	0.0169	CcSEcCtD
Desipramine—Acute coronary syndrome—Sorafenib—liver cancer	0.00071	0.0161	CcSEcCtD
Desipramine—Neuropathy peripheral—Sorafenib—liver cancer	0.000706	0.016	CcSEcCtD
Desipramine—Myocardial infarction—Sorafenib—liver cancer	0.000706	0.016	CcSEcCtD
Desipramine—Stomatitis—Sorafenib—liver cancer	0.000702	0.0159	CcSEcCtD
Desipramine—Jaundice—Sorafenib—liver cancer	0.000702	0.0159	CcSEcCtD
Desipramine—Tinnitus—Sorafenib—liver cancer	0.000603	0.0137	CcSEcCtD
Desipramine—Flushing—Sorafenib—liver cancer	0.0006	0.0136	CcSEcCtD
Desipramine—Petechiae—Epirubicin—liver cancer	0.000579	0.0131	CcSEcCtD
Desipramine—Arrhythmia—Sorafenib—liver cancer	0.000578	0.0131	CcSEcCtD
Desipramine—Alopecia—Sorafenib—liver cancer	0.000572	0.013	CcSEcCtD
Desipramine—Dysgeusia—Sorafenib—liver cancer	0.000551	0.0125	CcSEcCtD
Desipramine—Petechiae—Doxorubicin—liver cancer	0.000535	0.0122	CcSEcCtD
Desipramine—Ventricular extrasystoles—Epirubicin—liver cancer	0.000527	0.012	CcSEcCtD
Desipramine—Nocturia—Epirubicin—liver cancer	0.000513	0.0117	CcSEcCtD
Desipramine—Clomipramine—GSTP1—liver cancer	0.000504	0.159	CrCbGaD
Desipramine—Atrioventricular block—Epirubicin—liver cancer	0.000491	0.0111	CcSEcCtD
Desipramine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000488	0.0111	CcSEcCtD
Desipramine—Hypertension—Sorafenib—liver cancer	0.000486	0.011	CcSEcCtD
Desipramine—Coordination abnormal—Epirubicin—liver cancer	0.000485	0.011	CcSEcCtD
Desipramine—Ventricular tachycardia—Epirubicin—liver cancer	0.000476	0.0108	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000476	0.0108	CcSEcCtD
Desipramine—Nocturia—Doxorubicin—liver cancer	0.000475	0.0108	CcSEcCtD
Desipramine—Dry mouth—Sorafenib—liver cancer	0.000469	0.0106	CcSEcCtD
Desipramine—Atrioventricular block—Doxorubicin—liver cancer	0.000454	0.0103	CcSEcCtD
Desipramine—Thrombocytopenia—Sorafenib—liver cancer	0.00045	0.0102	CcSEcCtD
Desipramine—Coordination abnormal—Doxorubicin—liver cancer	0.000449	0.0102	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000441	0.01	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—liver cancer	0.000441	0.01	CcSEcCtD
Desipramine—Anorexia—Sorafenib—liver cancer	0.000438	0.00995	CcSEcCtD
Desipramine—Dyspepsia—Sorafenib—liver cancer	0.000405	0.00918	CcSEcCtD
Desipramine—Decreased appetite—Sorafenib—liver cancer	0.0004	0.00907	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000397	0.00902	CcSEcCtD
Desipramine—Fatigue—Sorafenib—liver cancer	0.000396	0.009	CcSEcCtD
Desipramine—Constipation—Sorafenib—liver cancer	0.000393	0.00892	CcSEcCtD
Desipramine—Vascular purpura—Epirubicin—liver cancer	0.000386	0.00877	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000368	0.00835	CcSEcCtD
Desipramine—Urticaria—Sorafenib—liver cancer	0.000365	0.00829	CcSEcCtD
Desipramine—Abdominal pain—Sorafenib—liver cancer	0.000363	0.00825	CcSEcCtD
Desipramine—Body temperature increased—Sorafenib—liver cancer	0.000363	0.00825	CcSEcCtD
Desipramine—Purpura—Epirubicin—liver cancer	0.000359	0.00814	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—liver cancer	0.000357	0.00812	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—liver cancer	0.000353	0.00801	CcSEcCtD
Desipramine—Purpura—Doxorubicin—liver cancer	0.000332	0.00753	CcSEcCtD
Desipramine—Asthenia—Sorafenib—liver cancer	0.00033	0.00749	CcSEcCtD
Desipramine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000326	0.00741	CcSEcCtD
Desipramine—Pruritus—Sorafenib—liver cancer	0.000325	0.00738	CcSEcCtD
Desipramine—Ataxia—Epirubicin—liver cancer	0.000325	0.00738	CcSEcCtD
Desipramine—Liver function test abnormal—Epirubicin—liver cancer	0.000319	0.00724	CcSEcCtD
Desipramine—Diarrhoea—Sorafenib—liver cancer	0.000314	0.00714	CcSEcCtD
Desipramine—Dizziness—Sorafenib—liver cancer	0.000304	0.0069	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—liver cancer	0.000301	0.00683	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—liver cancer	0.000296	0.00671	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—liver cancer	0.000295	0.0067	CcSEcCtD
Desipramine—Vomiting—Sorafenib—liver cancer	0.000292	0.00663	CcSEcCtD
Desipramine—Rash—Sorafenib—liver cancer	0.00029	0.00658	CcSEcCtD
Desipramine—Dermatitis—Sorafenib—liver cancer	0.00029	0.00657	CcSEcCtD
Desipramine—Headache—Sorafenib—liver cancer	0.000288	0.00654	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—liver cancer	0.000276	0.00626	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—liver cancer	0.000274	0.00621	CcSEcCtD
Desipramine—Nausea—Sorafenib—liver cancer	0.000273	0.0062	CcSEcCtD
Desipramine—Weight increased—Epirubicin—liver cancer	0.000272	0.00617	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—liver cancer	0.000266	0.00605	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—liver cancer	0.000261	0.00593	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—liver cancer	0.00026	0.00589	CcSEcCtD
Desipramine—Jaundice—Epirubicin—liver cancer	0.00026	0.00589	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—liver cancer	0.000255	0.0058	CcSEcCtD
Desipramine—Nortriptyline—CYP2E1—liver cancer	0.000253	0.0797	CrCbGaD
Desipramine—Weight increased—Doxorubicin—liver cancer	0.000252	0.00571	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—liver cancer	0.000249	0.00564	CcSEcCtD
Desipramine—Oxcarbazepine—ALB—liver cancer	0.000247	0.078	CrCbGaD
Desipramine—Drowsiness—Doxorubicin—liver cancer	0.000246	0.00559	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000242	0.00548	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—liver cancer	0.00024	0.00545	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—liver cancer	0.00024	0.00545	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—liver cancer	0.000239	0.00543	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—liver cancer	0.000238	0.0054	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—liver cancer	0.00023	0.00522	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—liver cancer	0.000223	0.00506	CcSEcCtD
Desipramine—Flushing—Epirubicin—liver cancer	0.000222	0.00504	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—liver cancer	0.000221	0.00502	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—liver cancer	0.00022	0.005	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—liver cancer	0.000214	0.00485	CcSEcCtD
Desipramine—Alopecia—Epirubicin—liver cancer	0.000211	0.0048	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—liver cancer	0.000206	0.00468	CcSEcCtD
Desipramine—Flushing—Doxorubicin—liver cancer	0.000205	0.00466	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—liver cancer	0.000204	0.00463	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—liver cancer	0.000198	0.00449	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—liver cancer	0.000196	0.00445	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—liver cancer	0.000195	0.00444	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—liver cancer	0.000193	0.00438	CcSEcCtD
Desipramine—Agitation—Epirubicin—liver cancer	0.000191	0.00434	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—liver cancer	0.000189	0.00428	CcSEcCtD
Desipramine—Malaise—Epirubicin—liver cancer	0.000188	0.00426	CcSEcCtD
Desipramine—Acepromazine—ALB—liver cancer	0.000187	0.059	CrCbGaD
Desipramine—Palpitations—Epirubicin—liver cancer	0.000184	0.00418	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—liver cancer	0.000181	0.00412	CcSEcCtD
Desipramine—Convulsion—Epirubicin—liver cancer	0.00018	0.00409	CcSEcCtD
Desipramine—Hypertension—Epirubicin—liver cancer	0.00018	0.00408	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—liver cancer	0.000179	0.00406	CcSEcCtD
Desipramine—Chlorpromazine—CYP2E1—liver cancer	0.000177	0.056	CrCbGaD
Desipramine—Agitation—Doxorubicin—liver cancer	0.000177	0.00402	CcSEcCtD
Desipramine—Anxiety—Epirubicin—liver cancer	0.000177	0.00401	CcSEcCtD
Desipramine—Imipramine—CYP2E1—liver cancer	0.000176	0.0557	CrCbGaD
Desipramine—Amitriptyline—CYP2E1—liver cancer	0.000175	0.0553	CrCbGaD
Desipramine—Discomfort—Epirubicin—liver cancer	0.000175	0.00397	CcSEcCtD
Desipramine—Malaise—Doxorubicin—liver cancer	0.000174	0.00394	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—liver cancer	0.000173	0.00393	CcSEcCtD
Desipramine—Confusional state—Epirubicin—liver cancer	0.000171	0.00389	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—liver cancer	0.00017	0.00386	CcSEcCtD
Desipramine—Oedema—Epirubicin—liver cancer	0.00017	0.00386	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—liver cancer	0.000167	0.00379	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—liver cancer	0.000166	0.00378	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—liver cancer	0.000166	0.00377	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—liver cancer	0.000166	0.00376	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—liver cancer	0.000163	0.00371	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—liver cancer	0.000162	0.00368	CcSEcCtD
Desipramine—Anorexia—Epirubicin—liver cancer	0.000162	0.00368	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—liver cancer	0.00016	0.00364	CcSEcCtD
Desipramine—Hypotension—Epirubicin—liver cancer	0.000159	0.0036	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—liver cancer	0.000158	0.0036	CcSEcCtD
Desipramine—Oedema—Doxorubicin—liver cancer	0.000157	0.00357	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—liver cancer	0.000154	0.00349	CcSEcCtD
Desipramine—Insomnia—Epirubicin—liver cancer	0.000154	0.00349	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—liver cancer	0.000153	0.00348	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—liver cancer	0.000153	0.00346	CcSEcCtD
Desipramine—Somnolence—Epirubicin—liver cancer	0.000151	0.00343	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—liver cancer	0.00015	0.0034	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—liver cancer	0.00015	0.00339	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—liver cancer	0.000148	0.00335	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—liver cancer	0.000147	0.00333	CcSEcCtD
Desipramine—Fatigue—Epirubicin—liver cancer	0.000146	0.00332	CcSEcCtD
Desipramine—Constipation—Epirubicin—liver cancer	0.000145	0.0033	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—liver cancer	0.000142	0.00323	CcSEcCtD
Desipramine—Clomipramine—ALB—liver cancer	0.000142	0.0448	CrCbGaD
Desipramine—Paraesthesia—Doxorubicin—liver cancer	0.000141	0.0032	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—liver cancer	0.00014	0.00318	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—liver cancer	0.00014	0.00317	CcSEcCtD
Desipramine—Nortriptyline—ALB—liver cancer	0.000139	0.0438	CrCbGaD
Desipramine—Dyspepsia—Doxorubicin—liver cancer	0.000138	0.00314	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—liver cancer	0.000137	0.0031	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—liver cancer	0.000135	0.00308	CcSEcCtD
Desipramine—Urticaria—Epirubicin—liver cancer	0.000135	0.00306	CcSEcCtD
Desipramine—Constipation—Doxorubicin—liver cancer	0.000134	0.00305	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—liver cancer	0.000134	0.00305	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—liver cancer	0.000134	0.00305	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—liver cancer	0.00013	0.00294	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—liver cancer	0.000125	0.00283	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—liver cancer	0.000124	0.00282	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—liver cancer	0.000124	0.00282	CcSEcCtD
Desipramine—Asthenia—Epirubicin—liver cancer	0.000122	0.00277	CcSEcCtD
Desipramine—Pruritus—Epirubicin—liver cancer	0.00012	0.00273	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—liver cancer	0.000116	0.00264	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—liver cancer	0.000113	0.00256	CcSEcCtD
Desipramine—Dizziness—Epirubicin—liver cancer	0.000112	0.00255	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—liver cancer	0.000111	0.00252	CcSEcCtD
Desipramine—Vomiting—Epirubicin—liver cancer	0.000108	0.00245	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—liver cancer	0.000108	0.00244	CcSEcCtD
Desipramine—Rash—Epirubicin—liver cancer	0.000107	0.00243	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—liver cancer	0.000107	0.00243	CcSEcCtD
Desipramine—Headache—Epirubicin—liver cancer	0.000106	0.00242	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—liver cancer	0.000104	0.00236	CcSEcCtD
Desipramine—Nausea—Epirubicin—liver cancer	0.000101	0.00229	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—liver cancer	9.99e-05	0.00227	CcSEcCtD
Desipramine—Rash—Doxorubicin—liver cancer	9.91e-05	0.00225	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—liver cancer	9.9e-05	0.00225	CcSEcCtD
Desipramine—Headache—Doxorubicin—liver cancer	9.85e-05	0.00224	CcSEcCtD
Desipramine—Chlorpromazine—ALB—liver cancer	9.74e-05	0.0307	CrCbGaD
Desipramine—Amitriptyline—ALB—liver cancer	9.63e-05	0.0304	CrCbGaD
Desipramine—Nausea—Doxorubicin—liver cancer	9.33e-05	0.00212	CcSEcCtD
Desipramine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	5.65e-06	3.25e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MTOR—liver cancer	5.65e-06	3.25e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—liver cancer	5.63e-06	3.24e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK8—liver cancer	5.63e-06	3.24e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—liver cancer	5.61e-06	3.23e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK8—liver cancer	5.6e-06	3.22e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—liver cancer	5.58e-06	3.21e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—liver cancer	5.58e-06	3.21e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—liver cancer	5.58e-06	3.21e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—liver cancer	5.49e-06	3.16e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1B—liver cancer	5.48e-06	3.16e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—liver cancer	5.48e-06	3.15e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—liver cancer	5.46e-06	3.14e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—liver cancer	5.45e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—liver cancer	5.44e-06	3.13e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—liver cancer	5.43e-06	3.12e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—liver cancer	5.43e-06	3.12e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1B—liver cancer	5.4e-06	3.1e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—liver cancer	5.39e-06	3.1e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—liver cancer	5.39e-06	3.1e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1B—liver cancer	5.39e-06	3.1e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—liver cancer	5.38e-06	3.09e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—liver cancer	5.38e-06	3.09e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	5.37e-06	3.09e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2—liver cancer	5.37e-06	3.09e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—liver cancer	5.37e-06	3.09e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	5.35e-06	3.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—liver cancer	5.34e-06	3.07e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—liver cancer	5.34e-06	3.07e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—liver cancer	5.33e-06	3.06e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CG—liver cancer	5.32e-06	3.06e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—liver cancer	5.31e-06	3.06e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	5.31e-06	3.05e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	5.3e-06	3.05e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	5.29e-06	3.05e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—liver cancer	5.29e-06	3.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—liver cancer	5.28e-06	3.04e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—liver cancer	5.28e-06	3.04e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—liver cancer	5.27e-06	3.03e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARA—liver cancer	5.26e-06	3.03e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—liver cancer	5.26e-06	3.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—liver cancer	5.26e-06	3.03e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—liver cancer	5.26e-06	3.02e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—liver cancer	5.25e-06	3.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—liver cancer	5.24e-06	3.02e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—liver cancer	5.24e-06	3.02e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	5.24e-06	3.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—liver cancer	5.24e-06	3.01e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—liver cancer	5.23e-06	3.01e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—liver cancer	5.23e-06	3.01e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—liver cancer	5.22e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—liver cancer	5.21e-06	3e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—liver cancer	5.2e-06	2.99e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—liver cancer	5.19e-06	2.99e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—liver cancer	5.19e-06	2.98e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—liver cancer	5.18e-06	2.98e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—liver cancer	5.17e-06	2.98e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—liver cancer	5.17e-06	2.97e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—liver cancer	5.16e-06	2.97e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—liver cancer	5.15e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—liver cancer	5.14e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—liver cancer	5.14e-06	2.96e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—liver cancer	5.14e-06	2.96e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—liver cancer	5.14e-06	2.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—liver cancer	5.13e-06	2.95e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—liver cancer	5.12e-06	2.95e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—liver cancer	5.12e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—liver cancer	5.11e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—liver cancer	5.1e-06	2.94e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—liver cancer	5.1e-06	2.93e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—liver cancer	5.1e-06	2.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—liver cancer	5.09e-06	2.93e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—liver cancer	5.09e-06	2.93e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—liver cancer	5.09e-06	2.93e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—liver cancer	5.08e-06	2.92e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	5.07e-06	2.92e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—liver cancer	5.06e-06	2.91e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—liver cancer	5.06e-06	2.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	5.06e-06	2.91e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—liver cancer	5.04e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—liver cancer	5.03e-06	2.89e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—liver cancer	5.02e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	5.01e-06	2.88e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—liver cancer	5e-06	2.88e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—liver cancer	5e-06	2.88e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—liver cancer	5e-06	2.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—liver cancer	4.99e-06	2.87e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—liver cancer	4.99e-06	2.87e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	4.98e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—liver cancer	4.97e-06	2.86e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—liver cancer	4.97e-06	2.86e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—liver cancer	4.96e-06	2.86e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—liver cancer	4.96e-06	2.85e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	4.95e-06	2.85e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—liver cancer	4.95e-06	2.85e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—liver cancer	4.94e-06	2.84e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	4.94e-06	2.84e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—liver cancer	4.93e-06	2.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—liver cancer	4.91e-06	2.82e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—liver cancer	4.9e-06	2.82e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	4.89e-06	2.81e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—liver cancer	4.89e-06	2.81e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—liver cancer	4.88e-06	2.81e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—liver cancer	4.86e-06	2.8e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—liver cancer	4.85e-06	2.79e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—liver cancer	4.85e-06	2.79e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—liver cancer	4.84e-06	2.78e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—liver cancer	4.84e-06	2.78e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—liver cancer	4.83e-06	2.78e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—liver cancer	4.82e-06	2.77e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—liver cancer	4.82e-06	2.77e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—liver cancer	4.81e-06	2.77e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—liver cancer	4.79e-06	2.76e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—liver cancer	4.78e-06	2.75e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—liver cancer	4.78e-06	2.75e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—liver cancer	4.77e-06	2.75e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—liver cancer	4.77e-06	2.74e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—liver cancer	4.76e-06	2.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—liver cancer	4.76e-06	2.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—liver cancer	4.74e-06	2.73e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.73e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—liver cancer	4.69e-06	2.7e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.68e-06	2.69e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—liver cancer	4.62e-06	2.66e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—liver cancer	4.62e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—liver cancer	4.58e-06	2.64e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—liver cancer	4.58e-06	2.63e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—liver cancer	4.56e-06	2.62e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—liver cancer	4.52e-06	2.6e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—liver cancer	4.52e-06	2.6e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—liver cancer	4.51e-06	2.59e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—liver cancer	4.5e-06	2.59e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—liver cancer	4.49e-06	2.58e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—liver cancer	4.48e-06	2.58e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—liver cancer	4.46e-06	2.57e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—liver cancer	4.45e-06	2.56e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—liver cancer	4.44e-06	2.56e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—liver cancer	4.44e-06	2.56e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—liver cancer	4.43e-06	2.55e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—liver cancer	4.43e-06	2.55e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—liver cancer	4.43e-06	2.55e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—liver cancer	4.42e-06	2.54e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—liver cancer	4.42e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—liver cancer	4.41e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—liver cancer	4.41e-06	2.54e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—liver cancer	4.39e-06	2.53e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—liver cancer	4.39e-06	2.52e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—liver cancer	4.36e-06	2.51e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—liver cancer	4.35e-06	2.5e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—liver cancer	4.33e-06	2.49e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—liver cancer	4.24e-06	2.44e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—liver cancer	4.22e-06	2.43e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—liver cancer	4.2e-06	2.41e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—liver cancer	4.19e-06	2.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—liver cancer	4.16e-06	2.39e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—liver cancer	4.15e-06	2.39e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—liver cancer	4.14e-06	2.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—liver cancer	4.13e-06	2.38e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—liver cancer	4.12e-06	2.37e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—liver cancer	4.12e-06	2.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—liver cancer	4.11e-06	2.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—liver cancer	4.11e-06	2.36e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—liver cancer	4.1e-06	2.36e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—liver cancer	4.1e-06	2.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—liver cancer	4.09e-06	2.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—liver cancer	4.08e-06	2.35e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—liver cancer	4.08e-06	2.35e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARA—liver cancer	4.06e-06	2.34e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	4.06e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—liver cancer	4.05e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—liver cancer	4.05e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—liver cancer	4.04e-06	2.33e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	4.04e-06	2.32e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—liver cancer	4.01e-06	2.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.96e-06	2.28e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—liver cancer	3.94e-06	2.27e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—liver cancer	3.93e-06	2.26e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—liver cancer	3.93e-06	2.26e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—liver cancer	3.91e-06	2.25e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—liver cancer	3.91e-06	2.25e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—liver cancer	3.88e-06	2.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—liver cancer	3.84e-06	2.21e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—liver cancer	3.82e-06	2.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—liver cancer	3.81e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—liver cancer	3.8e-06	2.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—liver cancer	3.78e-06	2.18e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—liver cancer	3.76e-06	2.16e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—liver cancer	3.75e-06	2.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—liver cancer	3.75e-06	2.16e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—liver cancer	3.74e-06	2.15e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—liver cancer	3.68e-06	2.11e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—liver cancer	3.67e-06	2.11e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—liver cancer	3.62e-06	2.08e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—liver cancer	3.59e-06	2.07e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—liver cancer	3.58e-06	2.06e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—liver cancer	3.57e-06	2.06e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—liver cancer	3.56e-06	2.05e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	3.51e-06	2.02e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—liver cancer	3.5e-06	2.02e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—liver cancer	3.5e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	3.49e-06	2.01e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—liver cancer	3.48e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	3.48e-06	2e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—liver cancer	3.47e-06	1.99e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—liver cancer	3.45e-06	1.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—liver cancer	3.45e-06	1.98e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	3.44e-06	1.98e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—liver cancer	3.4e-06	1.95e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—liver cancer	3.39e-06	1.95e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—liver cancer	3.39e-06	1.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—liver cancer	3.38e-06	1.95e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—liver cancer	3.37e-06	1.94e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—liver cancer	3.36e-06	1.93e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—liver cancer	3.36e-06	1.93e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—liver cancer	3.33e-06	1.92e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—liver cancer	3.32e-06	1.91e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—liver cancer	3.3e-06	1.9e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—liver cancer	3.3e-06	1.9e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—liver cancer	3.24e-06	1.87e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—liver cancer	3.24e-06	1.86e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—liver cancer	3.23e-06	1.86e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—liver cancer	3.22e-06	1.85e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—liver cancer	3.18e-06	1.83e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—liver cancer	3.15e-06	1.82e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—liver cancer	3.1e-06	1.79e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—liver cancer	3.1e-06	1.78e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—liver cancer	3.09e-06	1.78e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—liver cancer	3.08e-06	1.77e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—liver cancer	3.06e-06	1.76e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—liver cancer	3.05e-06	1.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—liver cancer	3.02e-06	1.74e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—liver cancer	2.92e-06	1.68e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—liver cancer	2.91e-06	1.67e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—liver cancer	2.86e-06	1.65e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—liver cancer	2.86e-06	1.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—liver cancer	2.86e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—liver cancer	2.85e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—liver cancer	2.84e-06	1.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—liver cancer	2.81e-06	1.62e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—liver cancer	2.7e-06	1.55e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.67e-06	1.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—liver cancer	2.64e-06	1.52e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.49e-06	1.43e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—liver cancer	2.21e-06	1.27e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—liver cancer	2.15e-06	1.24e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.11e-06	1.21e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—liver cancer	2.03e-06	1.17e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—liver cancer	1.72e-06	9.9e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.63e-06	9.35e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—liver cancer	1.33e-06	7.64e-06	CbGpPWpGaD
